Zeng, Jianfei
Zhang, Weizhi
Lu, Xiaobing
Zhou, Hui
Huang, Jing
Xu, Zhenyu
Liao, Hairong
Liang, Jiaquan
Liang, Meihong
Ye, Chan
Sun, Ting
Hu, Yutong
She, Qi
Chen, Haixia
Guo, Qian
Yan, LiuJiao
Wu, Renrong
Li, Zezhi http://orcid.org/0000-0001-9149-5800
Clinical trials referenced in this document:
Documents that mention this clinical trial
The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms
https://doi.org/10.1007/s00406-023-01679-7
Funding for this research was provided by:
Guangzhou municipal key discipline in medicine (2021-2023)
Open Project Program of State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (VRLAB2022 B02)
Shanghai Key Laboratory of Psychotic Disorders Open Grant (21-K03)
Guangzhou Key R&D Program Agriculture and Social Development Science and Technology Project (202206010034)
Tianjin Science and Technology Project (18ZXRHSY00100)
Opening Foundation of Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University (KF202202)
Guangzhou Municiple Health Commission (2023C-TS26)
Tertiary Education Scientific research project of Guangzhou Municipal Education Bureau (202234641)
Article History
Received: 30 September 2022
Accepted: 8 August 2023
First Online: 20 September 2023
Declarations
:
: The authors declared no potential conflicts of interest.
: This study was approved by institutional review board and informed consents were obtained from the participants or their guardians.